CONGRESS PHARMA
Board
1 director, no change since 2022Director
since 28-01-2022
term until 15-06-2027
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 15. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”deed of 19-02-2020
Mandates through the years
2 names, the dashed line is todayDirector
Director (not named in the articles)
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Director, since before 31-12-2020
-
- Director (not named in the articles), from 17-02-2020 to 08-03-2022
Control
Founder
This company
CONGRESS PHARMA
Equity €10,393
Loss €301 in 2025
Capital
- Contribution
- €1
- Shares
- 10
- Contribution per share
- €0.10
- Equity per share
- €1,039 in 2025
- Source
- deed of 19-02-2020
Articles of association
deed of 19-02-2020 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Tuesday of June at 17:00
Shareholders
At incorporation
deed of 19-02-2020 ↗
- 10 shares (100%) · in cash